AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 261: F998-F1006, 1991;
0363-6127/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nobes, M. S.
Right arrow Articles by Mendelsohn, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nobes, M. S.
Right arrow Articles by Mendelsohn, F. A.

AJP - Renal Physiology, Vol 261, Issue 6 998-1006, Copyright © 1991 by American Physiological Society


ARTICLES

Effects of angiotensin on renal cortical and papillary blood flows measured by laser-Doppler flowmetry

M. S. Nobes, P. J. Harris, H. Yamada and F. A. Mendelsohn
Department of Physiology, University of Melbourne, Parkville, Victoria, Australia.

The effects of angiotensin II (ANG II) or angiotensin III (ANG III) on renal cortical blood flow (CBF) or papillary blood flow (PBF) were investigated in Inactin-anesthetized young rats with the use of laser-Doppler flowmetry. Infusion of equimolar pressor doses of ANG II (300 ng.kg-1.min-1 iv) or ANG III (267 ng.kg-1.min-1) decreased CBF by 31 +/- 2.6% (P less than 0.001) and 20.3 +/- 3.2% (P less than 0.01), respectively but increased PBF by 19 +/- 6.1% (P less than 0.05) and 14.6 +/- 4.4% (P less than 0.05). The ANG II-induced increase in PBF was not prevented by aortic clamping to maintain constant renal perfusion pressure or pretreatment with the prostaglandin synthase inhibitor, indomethacin. The nonpeptide ANG II receptor antagonist, DuP 753 completely abolished the systemic and intrarenal effects of ANG II. After pretreatment with a kallikrein inhibitor, aprotinin, ANG II infusion increased mean arterial pressure but did not affect PBF, suggesting that kinins, but not prostaglandins, modulate the action of systemic ANG II on PBF. We conclude that circulating ANG II induces vasoconstriction in the cortex and also promotes the intrarenal production of kinins, which act to enhance papillary blood flow.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. L. Mattson and C. J. Meister
Renal cortical and medullary blood flow responses to L-NAME and ANG II in wild-type, nNOS null mutant, and eNOS null mutant mice
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R991 - R997.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. M. Duke, G. A. Eppel, R. E. Widdop, and R. G. Evans
Disparate Roles of AT2 Receptors in the Renal Cortical and Medullary Circulations of Anesthetized Rabbits
Hypertension, August 1, 2003; 42(2): 200 - 205.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Yuan, M. Liang, Z. Yang, E. Rute, N. Taylor, M. Olivier, and A. W. Cowley Jr.
Gene expression reveals vulnerability to oxidative stress and interstitial fibrosis of renal outer medulla to nonhypertensive elevations of ANG II
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2003; 284(5): R1219 - R1230.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Sarkis, K. L. Liu, M. Lo, and D. Benzoni
Angiotensin II and renal medullary blood flow in Lyon rats
Am J Physiol Renal Physiol, February 1, 2003; 284(2): F365 - F372.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. L. Mattson
Importance of the renal medullary circulation in the control of sodium excretion and blood pressure
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R13 - R27.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. I. Oliverio, M. Delnomdedieu, C. F. Best, P. Li, M. Morris, M. F. Callahan, G. A. Johnson, O. Smithies, and T. M. Coffman
Abnormal water metabolism in mice lacking the type 1A receptor for ANG II
Am J Physiol Renal Physiol, January 1, 2000; 278(1): F75 - F82.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. A. Omoro, D. S. A. Majid, S. S. El-Dahr, and L. G. Navar
Kinin influences on renal regional blood flow responses to angiotensin-converting enzyme inhibition in dogs
Am J Physiol Renal Physiol, February 1, 1999; 276(2): F271 - F277.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Szentivanyi Jr, C. Y. Maeda, and A. W. Cowley Jr
Local Renal Medullary L-NAME Infusion Enhances the Effect of Long-Term Angiotensin II Treatment
Hypertension, January 1, 1999; 33(1): 440 - 445.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. C. Ortiz, L. A. Fortepiani, F. M. Ruiz-Marcos, N. M. Atucha, and J. Garcia-Estan
Role of AT1 receptors in the renal papillary effects of acute and chronic nitric oxide inhibition
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R760 - R766.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. I. Madrid, M. Garcia-Salom, J. Tornel, M. de Gasparo, and F. J. Fenoy
Interactions Between Nitric Oxide and Angiotensin II on Renal Cortical and Papillary Blood Flow
Hypertension, November 1, 1997; 30(5): 1175 - 1182.
[Abstract] [Full Text]


Home page
HypertensionHome page
V. Gross, A. Lippoldt, W. Schneider, and F. C. Luft
Effect of Captopril and Angiotensin II Receptor Blockade on Pressure Natriuresis in Transgenic TGR(mRen-2)27 Rats
Hypertension, September 1, 1995; 26(3): 471 - 479.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online